2018 Annual Meeting

The 28th Annual ISEN Conference will be held at the NYU Kimmel and Global Centers in New York, NY on May 5 and 6, 2018.

2018 Call for Abstracts
2018 ISEN Annual Meeting & Course Brochure (291kb .pdf)

Save the Dates

ECT Certificate Course

Saturday, May 5, 2018
This one day certificate course on electroconvulsive therapy (ECT) will include lectures, hands-on practicum, and exam.

Register More Information

Annual Meeting

Sunday, May 6, 2018
This one day annual meeting will include plenary talks and workshops by leading experts with updates on ECT, TMS, and other novel forms of brain stimulation.

Register More Information


7:30 a.m. Registration & Continental Breakfast (Visit Exhibits)
8:30 a.m. Welcome and Opening Remarks [Pamela Sullivan, MD]
8:40 a.m. Morning Symposium — Beyond Depression: Other Indications for ECT and Other Neurostimulation Treatments [Pamela Sullivan, MD—Chair]
  • ECT and Neurostimulation Treatments for Schizophrenia and Mania [Jagadisha Thirthalli, MD]
  • ECT for Neurocognitive Disorders [Brent P. Forester MD, MSc]
  • ECT and TMS for PTSD [F. Andrew Kozel, MD, MSCR]
  • ECT for OCD: Still Obsolete? [Pascal Sienaert, MD, PhD]
10:40 a.m. Break (Visit Exhibits)
10:55 a.m. Panel Discussion [Morning Symposium Speakers]
11:40 a.m. Best Trainee Abstract Award [presented by Adriana P. Hermida, MD]
11:45 a.m. Journal of ECT Best Paper Award and Presentation [presented by W. Vaughn McCall, MD]
12:05 p.m. Lunch (Lunch Provided)
12:35 p.m. ISEN Business Meeting & President’s Report [Colleen Loo, MBBS, FRANZP, MD & Executive Officers]
1:00 p.m. Move To Workshop
1:10 p.m. Concurrent Afternoon Breakout Sessions
Participants will have the opportunity to attend two of the four unique sessions.
  • Workshop - ECT in the Digital Age [M. Justin Coffey, MD—Chair]
    • Big Data and ECT [Patrick Ying, MD]
    • ECT and Wikipedia [Kristina Bullard, MSN, RN, NE-BC]
    • Uses of the ISEN Listserv [M. Justin Coffey, MD]
  • Workshop — Brain Stimulation: Guidelines and New Developments [F. Andrew Kozel, MD, MSCR —Chair]
    • rTMS Treatment in Depression: Guidelines from the US National Network of Depression Centers [Irving Reti, MBBS, MD]
    • rTMS for Tough cases: Targeting Dimensions of Illness in Patients with Multiple Comorbidities  [Jonathan Downar, MD, PhD, FRCPC]
    • Home-based tDCS Depression Treatment with Remote Clinical Supervision: Promising Results from the First Study [Colleen Loo, MBBS, FRANZCP, MD
  • Research Symposium — Adriana P. Hermida, MD—Chair]
    • Is ECT dangerous? A Systematic Review and Pooled Analysis of ECT-Related Mortality Rates [Søren Dinesen Østergaard, MD, PhD]
    • Abstract Oral Presentation: Electroconvulsive Therapy Induces Volume Increase in the Human Dentate Gyrus [Akirhiro Takamiya, MD]
    • Electroconvulsive Therapy: Focus on Mechanism of Action [Irving Reti, MBBS, MD]
2:40 p.m. Break & Rotate Workshops (Visit Exhibitors)
3:05 p.m. Concurrent Afternoon Breakout Sessions
  • Workshop - ECT in the Digital Age (Repeated)
  • Workshop — Brain Stimulation: Guidelines and New Developments (Repeated)
  • Research Symposium Continued
    • Ketamine, ECT and Depression: (mis)Adventures in the K-hole [Declan McLoughlin, PhD, MRCPI, MRCPsych]
    • Abstract Oral Presentation: Long-term Neurocognitive Functioning after Electroconvulsive Therapy in Patients with Late Life Depression [Esmée Verwijk, PhD]
    • Iterative Strategies to Refine and Optimize DBS Surgery for Depression [Helen S. Mayberg, MD]
4:35 p.m. Move to Poster Session
4:45 p.m. Poster Session & Reception
5:30 p.m. Adjournment


For your convenience, this meeting has been arranged to coincide with the annual meeting of the American Psychiatric Association. It is recommended that hotel reservations be made well in advance. The registration fees include course materials, continental breakfast, refreshment breaks, lunch and Continuing Education Credits. Seating for the meeting is limited. Registrations will be accepted in the order received.

*Note: Participants who register on-site will be charged an additional fee of $50. Food and beverage can only be guaranteed for those who are preregistered.

Registration Fees

  • ISEN Physician Members $490 ($540 on-site registration)
  • ISEN Other Clinician Members $490 ($540 on-site registration)
  • ISEN Nurse Members $250 ($300 on-site registration)
  • ISEN Resident/Trainee Members $250 ($300 on-site registration)
  • ISEN Student Members* $150 ($200 on-site registration)
  • ISEN Abstract Poster/Oral Presenters** $250
  • Non-Member Physicians $870 ($920 on-site registration)
  • Non-Member Other Clinicians $870 ($920 on-site registration)
  • Non-Member Nurses $450 ($500 on-site registration)
  • Non-Member Residents/Trainees* $450 ($500 on-site registration)
  • Non-Member Students* $250 ($300-onsite registration)
  • Non-Member Abstract/Poster Oral Presenters** $450

*Requires Program Director Letter Program Director letters should be mailed to Kelly Coffey at

**Requires submission of abstract; one presenter per poster

If you require assistance with hearing, vision or mobility to make this conference accessible to you, please contact Kelly Coffey via phone, 631.678.6276 or email, at least three weeks prior to the conference date.

Digital Materials

In lieu of paper printed programs, all event and course materials will be available in digital format. Registrants will have access to program information, including slide sets received from speakers in advance of the meeting, via a password protected page on the ISEN website. Registrants will be able to download materials, and if they wish, print paper copies. Registered attendees: To access materials, first log in to your ISEN account used to register for the event. Then, simply click your name in the upper right hand corner of the site page to view your profile. Links to the slides can be found on your profile page under your Account Information.

Registration Deadline

Friday, April 20, 2018. (Registrations will be taken after the deadline date based on space availability.)

Refund Policy

A refund of the registration fee, less an $85 processing fee, will be made when a written request followed by a written confirmation is received prior to April 20, 2018. After this date, refunds cannot be made. Fees will not be refunded for failure to attend. The sponsors of the course reserve the right to cancel or postpone any conference because of unforeseen circumstances or insufficient enrollment. In the event of such cancellations, full tuition will be refunded.

Intended Audience

This year’s conference is intended for practitioners, mental health professionals and researchers of ECT and related stimulation techniques. The conference will focus on preventing relapse and will provide an update on the current practices, research and technical issues in ECT, TMS, DBS, tDCS, MST and other brain stimulation modalities. A poster session will allow for the most recent research in ECT and other brain stimulation modalities to be presented. The information presented in this CME offering reflects the opinion of the presenters. As with all science, there may be multiple explanations for the data and multiple reasonable conclusions. ISEN reserves the right to refuse registration, or refund registration fees, to any person whose presence has the potential to be disruptive and/or not consistent with the mission and goals of the organization.


At the conclusion of the conference, participants should be able to:

  • describe the use of ECT and other forms of brain stimulation to treat schizophrenia and bipolar disorder.
  • describe the use of ECT to treat obsessive compulsive disorder and neurocognitive disorders.
  • describe the use of TMS and ECT to treat post-traumatic stress disorder.
  • identify and evaluate contemporary electronic sources of information about ECT.
  • review the roles, applications, and clinical studies of novel brain stimulation techniques (TMS, tDCS) in the treatment of depression.               
  • review educational initiatives related to developments in the fields of TMS and tDCS and understand how TMS treatment may be improved.
  • appreciate emerging strategies to define acute and chronic antidepressant effects of subcallosal cingulate DBS, gain knowledge about the potential role of ketamine in ECT practice and understand ECT’s action as an antidepressant.


This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Professional Education Services Group (PESG) and ISEN. This activity will provide continuing education for physicians and psychologists, as well as a general participation CE certificate for other attendees. This activity is approved for up to 6.75 hours of continuing education.

Professional Education Services Group is accredited by the ACCME to provide continuing medical education for physicians. Physicians should only claim credit to the extent of their participation. The American Nurses Credentialing Center accepts AMA PRA Category 1 Credits issued by organizations accredited by the ACCME. The University of Denver is approved by the American Psychological Association to sponsor continuing education for psychologists. APA Division 22 maintains responsibility for this program and its content.

Venue & Accommodations

Venue Information

NYU Kimmel and Global Centers 60 Washington Square South New York, NY 10012

NYU Kimmel and Global Centers border Washington Square Park, located in the heart of New York’s Greenwich Village.  The sidewalks are full of students on their way to class, and members of the NYU community fill the restaurants, shops, and other businesses.


Attendees are responsible for booking overnight accommodations if needed. A block of rooms has not been reserved at any one hotel. A few nearby hotels to consider:

Disclosure of Commercial Relationships

In compliance with the ACCME Standards for Commercial Support, all individuals in a position to control/influence the content of this activity are required to disclose relevant financial interests of their own or spouse or partners with any commercial interests and/or non-FDA approved use of a drug or a device that is included in the presentation.

Enhancing Communication Services for the Deaf or Hard-of-Hearing

If you require assistance with hearing, vision or mobility to make this conference accessible to you, please contact Kelly Coffey at at least three weeks prior to the conference date.

Questions? Please email: